Life beyond 5 Years after TAVI: Patients’ Perceived Health Status and Long-Term Outcome after Transcatheter Aortic Valve Implantation

Table 1

Baseline characteristics before TAVI and at late follow-up.

Variable	Total (n = 103)
Before TAVI
Age, years at TAVI	80.1 ± 7.9 (30–92),
Female, n (%)	58 (56.3)
BMI (kg/m^2)	27.5 ± 4.3
STS score	9.1 ± 5.6
Logistic EuroScore	18.1 ± 11.7
NYHA functional class III to IV	65 (67.0)
Hypertension, n (%)	92 (89.3)
Diabetes mellitus, n (%)	23 (22.3)
CKD, (GFR <60 ml/min), n (%)	63 (61.2)
Previous MI, n (%)	19 (18.4)
Previous PCI, n (%)	52 (51.5)
Previous CABG, n (%)	10 (9.7)
Permanent pacemaker	16 (15.5)
COPD, n (%)	15 (14.7)
Prior CVA/TIA	12 (11.6)
Atrial fibrillation/atrial flutter	36 (35.0)
At late follow-up
Age, years	86.5 ± 8.0 (37–98)
Female, n (%)	56 (56.6)

Data are expected as absolute values (n) and percentages (%) or as mean ± standard deviation (SD). TAVI, transcatheter aortic valve implantation; n, number; BMI, body mass index; STS, society of thoracic surgery; NYHA, New York Heart Association; CKD, chronic kidney disease; MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; COPD, chronic obstructive pulmonary disease; CVA; cerebrovascular accident; TIA, transient ischemic attack.